- Report
- April 2026
- 150 Pages
Canada
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Germany
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
India
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Indonesia
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Japan
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Malaysia
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Netherlands
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
China
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Saudi Arabia
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
South Africa
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Spain
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Thailand
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
Turkey
From €4351EUR$4,850USD£3,719GBP
- Report
- April 2026
- 150 Pages
South Korea
From €4351EUR$4,850USD£3,719GBP
- Report
- May 2025
- 119 Pages
Global
From €2646EUR$2,950USD£2,262GBP
- Report
- February 2025
- 140 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- September 2024
- 97 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- April 2024
- 74 Pages
Global
From €4171EUR$4,650USD£3,566GBP
- Directory
- August 2022
- 1046 Pages
Japan
From €8926EUR$9,950USD£7,631GBP
- Report
- October 2022
- 94 Pages
Global
From €1794EUR$2,000USD£1,534GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more